{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:01:56Z","timestamp":1789563716608,"version":"build-2803163510"},"reference-count":66,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Mitochondrial disorders are a clinically heterogeneous group of disorders that are caused by defects in the respiratory chain, the metabolic pathway of the adenosine tri-phosphate (ATP) production system. Epilepsy is a common and important feature of these disorders and its management can be challenging. Epileptic seizures in the context of mitochondrial disease are usually treated with conventional anti-epileptic medication, apart from valproic acid. However, in accordance with the treatment of intractable epilepsy where there are limited treatment options, the ketogenic diet (KD) has been considered as an alternative therapy. The use of the KD and its more palatable formulations has shown promising results. It is especially indicated and effective in the treatment of mitochondrial disorders due to complex I deficiency. Further research into the mechanism of action and the neuroprotective properties of the KD will allow more targeted therapeutic strategies and thus optimize the treatment of both epilepsy in the context of mitochondrial disorders but also in other neurodegenerative disorders.<\/jats:p>","DOI":"10.3390\/jcm6060056","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T04:35:42Z","timestamp":1496118942000},"page":"56","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Use of the Ketogenic Diet to Treat Intractable Epilepsy in Mitochondrial Disorders"],"prefix":"10.3390","volume":"6","author":[{"given":"Eleni","family":"Paleologou","sequence":"first","affiliation":[{"name":"Chelsea and Westmister Hospital, 369 Fulham road, Chelsea, London SW10 9NH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Ismayilova","sequence":"additional","affiliation":[{"name":"Chelsea and Westmister Hospital, 369 Fulham road, Chelsea, London SW10 9NH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kinali","sequence":"additional","affiliation":[{"name":"Chelsea and Westmister Hospital, 369 Fulham road, Chelsea, London SW10 9NH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1528-1167.2012.03618.x","article-title":"Mitochondrial diseases and epilepsy","volume":"53","author":"Bindoff","year":"2012","journal-title":"Epilepsia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ceca.2016.03.003","article-title":"Mitochondrial cytopathies","volume":"60","author":"Scaglia","year":"2016","journal-title":"Cell Calcium"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/WNL.13.11.919","article-title":"Rapid examination of muscle tissue: An improved trichrome stain method for fresh frozen biopsy sections","volume":"13","author":"Engel","year":"1963","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-61779-504-6_13","article-title":"Blue native polyacrylamide gel electrophoresis: A powerful diagnostic tool for the detection of assembly defects in the enzyme complexes of oxidative phosphorylation","volume":"837","author":"Leary","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1517\/17530059.2013.812070","article-title":"Fibroblast Growth Factor 21: A novel biomarker for human muscle-manifesting mitochondrial disorders","volume":"7","author":"Suomalainen","year":"2013","journal-title":"Expert Opin. Med. Diagn."},{"key":"ref_7","unstructured":"Hirano, M. Personal communication."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","article-title":"Mitochondrial disease: Genetics and management","volume":"263","author":"Ng","year":"2016","journal-title":"J. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Pfeffer, G., Majamaa, K., Turnbull, D., Thorburn, D.R., and Chinnery, P.F. (2012). Treatment for mitochondrial disorders. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD004426.pub3"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.seizure.2012.03.003","article-title":"Epilepsy in mitochondrial disorders","volume":"21","author":"Finsterer","year":"2012","journal-title":"Seizure"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1528-1167.2009.02504.x","article-title":"Epileptic phenotypes in children with respiratory chain disorders","volume":"51","author":"Lebre","year":"2010","journal-title":"Epilepsia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/epi.12570","article-title":"Seizure semiology and EEG findings in mitochondrial diseases","volume":"55","author":"Chevallier","year":"2014","journal-title":"Epilepsia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1528-1167.2007.01522.x","article-title":"Mitochondrial respiratory chain defects: Underlying etiology in various epileptic conditions","volume":"49","author":"Lee","year":"2008","journal-title":"Epilepsia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ana.24525","article-title":"Epilepsy in adults with mitochondrial disease: A cohort study","volume":"78","author":"Whittaker","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425255.2012.644535","article-title":"Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders","volume":"8","author":"Finsterer","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","article-title":"Levetiracetam inhibits the high voltage activated Ca2+ current in pyramidal neurones of rat hippocampal slices","volume":"306","author":"Niespodziany","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biocel.2015.01.022","article-title":"Mitochondria: The ketogenic diet\u2014A metabolism-based therapy","volume":"63","author":"Vidali","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1194\/jlr.R048975","article-title":"Ketogenic diets, mitochondria, and neurological diseases","volume":"55","author":"Gano","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10863-010-9320-9","article-title":"Mitochondrial dysfunction and oxidative stress: A contributing link to acquired epilepsy?","volume":"42","author":"Waldbaum","year":"2010","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/1570159X12666140923205715","article-title":"Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status","volume":"12","author":"Martinc","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2013.02.002","article-title":"Mitochondrial involvement and oxidative stress in temporal lobe epilepsy","volume":"62","author":"Rowley","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/157015912804499447","article-title":"The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress","volume":"10","author":"Martinc","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(98)00648-7","article-title":"Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice","volume":"359","author":"Urbanska","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1043S","DOI":"10.1093\/jn\/130.4.1043S","article-title":"Glutamate and epilepsy","volume":"130","author":"Chapman","year":"2000","journal-title":"J. Nutr."},{"key":"ref_25","first-page":"1796","article-title":"Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death","volume":"125","author":"Kovac","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1017\/S0317167100013676","article-title":"Ketogenic diet","volume":"40","author":"Dhamija","year":"2013","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/adc.2009.159848","article-title":"The ketogenic diet in childhood epilepsy: Where are we now?","volume":"95","author":"Cross","year":"2010","journal-title":"Arch. Dis. Child"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.seizure.2010.10.021","article-title":"Dietary therapies\u2014An old idea with a new lease of life","volume":"19","author":"Cross","year":"2010","journal-title":"Seizure"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11940-008-0043-8","article-title":"The ketogenic diet: Uses in epilepsy and other neurologic illnesses","volume":"10","author":"Baranano","year":"2008","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yebeh.2016.12.018","article-title":"Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital","volume":"68","author":"Grocott","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ejpn.2016.07.009","article-title":"Ketogenic diet guidelines for infants with refractory epilepsy","volume":"20","author":"Neal","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","article-title":"The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial","volume":"7","author":"Neal","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","article-title":"New insights into the mechanisms of the ketogenic diet","volume":"30","author":"Boison","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1528-1157.2000.tb00115.x","article-title":"Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet","volume":"41","author":"Likhodii","year":"2000","journal-title":"Epilepsia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1006\/exnr.1999.7298","article-title":"The MCT ketogenic diet: Effects on animal seizure models","volume":"161","author":"Thavendiranathan","year":"2000","journal-title":"Exp. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/brain\/awv325","article-title":"Seizure control by decanoic acid through direct AMPA receptor inhibition","volume":"139","author":"Chang","year":"2016","journal-title":"Brain"},{"key":"ref_38","first-page":"947","article-title":"AMPA receptors in epilepsy and as targets for antiepileptic drugs","volume":"79","author":"Rogawski","year":"1999","journal-title":"Adv. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pnpbp.2014.10.013","article-title":"Acute anticonvulsant effects of capric acid in seizure tests in mice","volume":"57","author":"Wlaz","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jnc.12646","article-title":"The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells","volume":"129","author":"Hughes","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MCO.0b013e3282f44c06","article-title":"The ketogenic diet and epilepsy","volume":"11","author":"Kim","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-016-2336-7","article-title":"Control of seizures by ketogenic diet-induced modulation of metabolic pathways","volume":"49","author":"Clanton","year":"2017","journal-title":"Amino Acids"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Noebels, J.L., Avoli, M., Rogawski, M.A., Olsen, R., and Delgado-Escueta, A. (2012). Mechanisms of Ketogenic Diet Action. Jasper\u2019s Basic Mechanisms of the Epilepsies, National Center for Biotechnology Information. [4th ed.].","DOI":"10.1093\/med\/9780199746545.001.0001"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.20899","article-title":"Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet","volume":"60","author":"Bough","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","article-title":"Metabolic Control of Vesicular Glutamate Transport and Release","volume":"68","author":"Juge","year":"2010","journal-title":"Neuron"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1471-4159.2012.07670.x","article-title":"Ketone Bodies in Epilepsy","volume":"121","author":"McNally","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kim, D.Y., Abdelwahab, M.G., Lee, S.H., O\u2019Neil, D., Thompson, R.J., Duff, H.J., Sullivan, P.G., and Rho, J.M. (2015). Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119316"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","article-title":"A randomised trial of classical and medium-chained Triglyceride ketogenic diets in the treatment of childhood epilepsy","volume":"50","author":"Neal","year":"2009","journal-title":"Epilepsia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","article-title":"Seizure control by ketogenic diet-associated medium chain fatty acids","volume":"69","author":"Chang","year":"2013","journal-title":"Neuropharnacology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/WCO.0b013e3283515e4a","article-title":"Ketogenic diets: New advances for metabolism-based therapies","volume":"25","author":"Kossoff","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1212\/01.wnl.0000187071.24292.9e","article-title":"Low glycaemic index treatment: A liberalized ketogenic diet for treatment if intractable epilepsy","volume":"65","author":"Pfeiffer","year":"2005","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1528-1167.2008.01831.x","article-title":"The modified Atkins diet","volume":"9","author":"Kossoff","year":"2008","journal-title":"Epilepsia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.yebeh.2013.09.032","article-title":"A decade of the modified Atkins diet (2003\u20132013): Results, insights and future directions","volume":"29","author":"Kossoff","year":"2013","journal-title":"Epilepsy Behav."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/eci.12591","article-title":"Ketogenic diets: From cancer to mitochondrial diseases and beyond","volume":"46","author":"Branco","year":"2016","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1528-1167.2008.01959.x","article-title":"Efficacy, safety and tolerability of the low glycaemic index treatment in paediatric epilepsy","volume":"50","author":"Muzykewicz","year":"2009","journal-title":"Epilepsia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1684\/epd.2012.0543","article-title":"Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet","volume":"14","author":"Martikainen","year":"2012","journal-title":"Epileptic Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1528-1167.2006.00906.x","article-title":"Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects","volume":"48","author":"Kang","year":"2007","journal-title":"Epilepsia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1471-4159.2008.05460.x","article-title":"The ketogenic diet increases mitochondrial glutathione levels","volume":"106","author":"Jarrett","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.braindev.2008.12.020","article-title":"A case of Ohtahara syndrome with mitochondrial respiratory chain complex I deficiency","volume":"32","author":"Seo","year":"2010","journal-title":"Brain Dev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pediatrneurol.2006.01.012","article-title":"Landau Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency","volume":"35","author":"Kang","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1469-8749.2009.03541.x","article-title":"Pyruvate dehydrogenase complex deficiency: Four neurological phenotypes with differing pathogenesis","volume":"52","author":"Barnerias","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.seizure.2010.06.006","article-title":"Long-term outcome and tolerability of the ketogenic diet in drug resistant childhood epilepsy\u2014The Austrian experience","volume":"19","author":"Dressler","year":"2010","journal-title":"Seizure"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yebeh.2015.12.011","article-title":"Ketogenic diet effects on neurobehavioral development of children with intractable epilepsy: A prospective study","volume":"55","author":"Zhu","year":"2016","journal-title":"Epilepsy Behav."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2016.08.002","article-title":"Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model","volume":"96","author":"Ciarlone","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2015.05.023","article-title":"Anticonvulsant properties of an oral ketone ester in a pentylenetetrazole-model of seizure","volume":"1618","author":"Viggiano","year":"2015","journal-title":"Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.aaa1299","article-title":"Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy","volume":"347","author":"Sada","year":"2015","journal-title":"Science"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/6\/6\/56\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:37:06Z","timestamp":1760207826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/6\/6\/56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["jcm6060056"],"URL":"https:\/\/doi.org\/10.3390\/jcm6060056","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]}}}